{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:04:42Z","timestamp":1789646682828,"version":"4.0.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"DOI":"10.1038\/s41571-026-01206-2","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:46:19Z","timestamp":1789645579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Armouring GPC3 CAR T cells for hepatocellular carcinoma: how much is enough and what comes next?"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0806-2535","authenticated-orcid":false,"given":"Tim F.","family":"Greten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9152-5405","authenticated-orcid":false,"given":"Mitchell","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"1206_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41586-023-05707-3","volume":"614","author":"L Labanieh","year":"2023","unstructured":"Labanieh, L. & Mackall, C. L. CAR immune cells: design principles, resistance and the next generation. Nature 614, 635\u2013648 https:\/\/doi.org\/10.1038\/s41586-023-05707-3 (2023).","journal-title":"Nature"},{"key":"1206_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41586-026-10786-z","volume":"657","author":"Q Zhang","year":"2026","unstructured":"Zhang, Q. et al. GPC3-specific dnTGFbetaRII-armoured CAR T cells for hepatocellular carcinoma. Nature 657, 495\u2013504 https:\/\/doi.org\/10.1038\/s41586-026-10786-z (2026).","journal-title":"Nature"},{"key":"1206_CR3","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41586-024-08261-8","volume":"637","author":"D Steffin","year":"2025","unstructured":"Steffin, D. et al. Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers. Nature 637, 940\u2013946 https:\/\/doi.org\/10.1038\/s41586-024-08261-8 (2025).","journal-title":"Nature"},{"key":"1206_CR4","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1053\/j.gastro.2020.02.011","volume":"158","author":"D Li","year":"2020","unstructured":"Li, D. et al. Persistent polyfunctional chimeric antigen receptor T cells that target glypican 3 eliminate orthotopic hepatocellular carcinomas in mice. Gastroenterology 158, 2250\u20132265.e20 https:\/\/doi.org\/10.1053\/j.gastro.2020.02.011 (2020).","journal-title":"Gastroenterology"},{"key":"1206_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2025.102000","volume":"81","author":"L Kocheise","year":"2026","unstructured":"Kocheise, L., Benmebarek, M.-R., Ho, M. & Greten, T. F. Chimeric antigen receptor therapy for hepatocellular carcinoma. Semin. Immunol. 81, 102000 https:\/\/doi.org\/10.1016\/j.smim.2025.102000 (2026).","journal-title":"Semin. Immunol."},{"key":"1206_CR6","unstructured":"US Food and Drug Administration. Considerations for the development of chimeric antigen receptor (CAR) T cell products. FDA https:\/\/www.fda.gov\/media\/156896\/download (2024)."},{"key":"1206_CR7","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2967\/jnumed.124.268147","volume":"65","author":"AJ Poot","year":"2024","unstructured":"Poot, A. J. et al. [(68)Ga]Ga-RAYZ-8009: a glypican-3-targeted diagnostic radiopharmaceutical for hepatocellular carcinoma molecular imaging-a first-in-human case series. J. Nucl. Med. 65, 1597\u20131603 https:\/\/doi.org\/10.2967\/jnumed.124.268147 (2024).","journal-title":"J. Nucl. Med."},{"key":"1206_CR8","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/S0140-6736(25)00860-8","volume":"405","author":"C Qi","year":"2025","unstructured":"Qi, C. et al. Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial. Lancet 405, 2049\u20132060 https:\/\/doi.org\/10.1016\/S0140-6736(25)00860-8 (2025).","journal-title":"Lancet"}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01206-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01206-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01206-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:46:21Z","timestamp":1789645581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41571-026-01206-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":8,"alternative-id":["1206"],"URL":"https:\/\/doi.org\/10.1038\/s41571-026-01206-2","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"value":"1759-4774","type":"print"},{"value":"1759-4782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"17 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}